Filgotinib for Treating Moderately to Severely Active Ulcerative Colitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
暂无分享,去创建一个
M. Joore | M. Kimman | F. Hoentjen | S. Grimm | N. Armstrong | Charlotte Ahmadu | L. Stirk | A. V. van Asselt | T. Govers | A. Peeters | K. McDermott | Sabine E. Grimm | Antoinette D. I. van Asselt